Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이준호 | - |
dc.date.accessioned | 2021-11-09T01:38:05Z | - |
dc.date.available | 2021-11-09T01:38:05Z | - |
dc.date.issued | 2020-04 | - |
dc.identifier.citation | INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, v. 63, no. 2, page. 221-225 | en_US |
dc.identifier.issn | 0377-4929 | - |
dc.identifier.issn | 0974-5130 | - |
dc.identifier.uri | https://www.ijpmonline.org/article.asp?issn=0377-4929;year=2020;volume=63;issue=2;spage=221;epage=225;aulast=Lee | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/166170 | - |
dc.description.abstract | Context: The function of ASXL1 in colorectal cancer ( CRC) has not been investigated yet. Aims: The purpose of this study was to investigate the clinicopathological and prognostic impact of ASXL1 expression on CRC. Settings and Design: The intensity of expression was scored as 0-3, and the extent of staining was scored as 0-4, based on the percentage of positive cells. The immunoreactivity score (IRS) was calculated by multiplying the two scores. Materials and Methods: We performed immunohistochemical staining of ASXL1 using tissue microarrays of 408 CRCs, 46 normal colonic mucosae, 48 adenomas, and 92 metastatic lymph nodes. Statistical Analysis Used: Clinicopathological variables were compared using Fisher's exact test, chi(2)-test, or unpaired Student's t-test, depending on the nature of the data. Results: A negative expression of ASXL1 was observed in 10.9% of normal mucosae, 27.1% of adenomas, 55.6% of adenocarcinomas, and 71.7% of metastatic lymph nodes (P < 0.001). With respect to the IRS cut-off score, lymph node metastasis and lymphatic invasion were more frequent in the IRS 0-6 group than in the IRS 8-12 group (56.3% vs. 33.3%, P = 0.034; 56.0% vs. 33.3%, P = 0.035). The 5-year disease-free survival rate was significantly lower in patients with IRS 0-6 group than those with IRS 8-12 group (78.7 +/- 2.5 vs. 100%, P = 0.034). Conclusion: ASXL1 might act as a tumor suppressor in CRC. The loss of ASXL1 expression might be associated with lymph node metastasis and lymphatic invasion in CRC. | en_US |
dc.description.sponsorship | This work was supported by the research fund of Hanyang University (HY-2015). | en_US |
dc.language.iso | en | en_US |
dc.publisher | WOLTERS KLUWER MEDKNOW PUBLICATIONS | en_US |
dc.subject | ASXL1 | en_US |
dc.subject | colorectal cancer | en_US |
dc.subject | lymph node | en_US |
dc.subject | metastasis | en_US |
dc.subject | prognosis | en_US |
dc.title | Loss of ASXL1 expression is associated with lymph node metastasis in colorectal cancer | en_US |
dc.type | Article | en_US |
dc.relation.no | 2 | - |
dc.relation.volume | 63 | - |
dc.identifier.doi | 10.4103/IJPM.IJPM_822_19 | - |
dc.relation.page | 221-225 | - |
dc.relation.journal | INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY | - |
dc.contributor.googleauthor | Lee, Jun H. | - |
dc.contributor.googleauthor | Lee, Ju-Hee | - |
dc.contributor.googleauthor | Ahn, Byung K. | - |
dc.contributor.googleauthor | Paik, Seung S. | - |
dc.contributor.googleauthor | Kim, Hyunsung | - |
dc.contributor.googleauthor | Lee, Kang H. | - |
dc.relation.code | 2020051406 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | duno82 | - |
dc.identifier.orcid | https://orcid.org/0000-0001-9651-4222 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.